Sort
23,748 grants matching “melanoma”
PHARMACOLOGICAL TARGETING OF GALPHA SUBUNITS IN DISEASE
$446,968Kendall Jay Blumer · Washington University · R01 · FY2019 · GM
PHARMACOLOGICAL TARGETING OF GALPHA SUBUNITS IN DISEASE
$446,968Kendall Jay Blumer · Washington University · R01 · FY2017 · GM
PHARMACOLOGICAL TARGETING OF GALPHA SUBUNITS IN DISEASE
$446,968Kendall Jay Blumer · Washington University · R01 · FY2018 · GM
Developmental Funds
$446,848Dario C. Altieri · Wistar Institute · P30 · FY2014 · CA
Function of IL35+ B cells in pancreatic cancer
$446,826Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2021 · CA
Targeting the MET Pathway in Urothelial Carcinoma
$446,627Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Transport of Effector T cells and Nano-DC vaccine in Breast Cancer
$446,417Rongfu Wang · Methodist Hospital Research Institute · U54 · FY2020 · CA
HIGH THROUGHPUT FTICR FOR MOLECULAR ANALYSIS OF CANCER
$446,398Battelle Pacific Northwest Laboratories · R33 · FY2001 · CA
Targeting Lipid Metabolism in the Tumor Microenvironment
$446,352Ashani T Weeraratna · Wistar Institute · P01 · FY2020 · CA
Molecular Interactions and Imaging Core
$446,346Henry N Higgs · Dartmouth College · P20 · FY2024 · GM
Molecular Interactions and Imaging Core
$446,346Henry N Higgs · Dartmouth College · P20 · FY2025 · GM
Molecular Interactions and Imaging Core
$446,346Henry N Higgs · Dartmouth College · P20 · FY2021 · GM
Molecular Interactions and Imaging Core
$446,346Henry N Higgs · Dartmouth College · P20 · FY2022 · GM
Molecular Interactions and Imaging Core
$446,346Henry N Higgs · Dartmouth College · P20 · FY2023 · GM
Targeting innate immune pathways in breast cancers with chromosomal instability
$446,239Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
Targeting HSP70 for MelanomaTherapy
$446,169Maureen E Murphy · Wistar Institute · P01 · FY2023 · CA
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$446,134Ralph R Weichselbaum · University Of Chicago · R01 · FY2023 · CA
The role of transcription elongation defects in immunotherapy resistance in cancers
$446,129Fukun Guo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA
The role of transcription elongation defects in immunotherapy resistance in cancers
$446,129Fukun Guo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · CA
The role of transcription elongation defects in immunotherapy resistance in cancers
$446,129Fukun Guo · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · CA
Targeting autophagy to enhance immune checkpoint inhibition
$445,954Ravi K Amaravadi · Wistar Institute · P50 · FY2022 · CA
Project 1: Nanotherapies for Vemurafenib Resistant Melanoma
$445,923Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2019 · CA
XAI-TRUST: Explainable AI Techniques to Rigorously Understand, Scrutinize, and Trust Clinical AI
$445,848Su-In Lee · University Of Washington · R01 · FY2025 · EB
Project 2: Understanding the Cellular Origins of Melanoma
$445,780Anand K Ganesan · University Of California-Irvine · U54 · FY2019 · CA
Post-translational control of cancer cell stress response and metastasis
$445,719Iannis Aifantis · New York University School Of Medicine · R01 · FY2019 · CA